カテゴリー： QYResearch, 世界

世界の色素性絨毛結節性滑膜炎薬市場 2019年

【英語タイトル】Global Pigmented Villonodular Synovitis Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X13012）・商品コード：DATA909X13012
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：101
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、色素性絨毛結節性滑膜炎薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カビラリズマブ、エマツズマブ、Mcs-110、ニロチニブ、その他に、用途別には、病院、クリニック、その他にセグメント区分し、色素性絨毛結節性滑膜炎薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・色素性絨毛結節性滑膜炎薬の世界市場概要
・色素性絨毛結節性滑膜炎薬の製造コスト構成分析
・色素性絨毛結節性滑膜炎薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・色素性絨毛結節性滑膜炎薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・色素性絨毛結節性滑膜炎薬のセグメント分析（種類別）
（カビラリズマブ、エマツズマブ、Mcs-110、ニロチニブ、その他）
・色素性絨毛結節性滑膜炎薬のセグメント分析（用途別）
（病院、クリニック、その他）
・色素性絨毛結節性滑膜炎薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Bristol-Myers Squibb Co、F. Hoffmann-La Roche Ltd、Novartis AG、Plexxikon Inc、）
・色素性絨毛結節性滑膜炎薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Pigmented Villonodular Synovitis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Pigmented Villonodular Synovitis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pigmented Villonodular Synovitis Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Pigmented Villonodular Synovitis Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Pigmented Villonodular Synovitis Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bristol-Myers Squibb Co
F. Hoffmann-La Roche Ltd
Novartis AG
Plexxikon Inc
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Cabiralizumab
Emactuzumab
Mcs-110
Nilotinib
Others

Segment by Application
Hospital
Clinic
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Pigmented Villonodular Synovitis Drug
1.1 Definition of Pigmented Villonodular Synovitis Drug
1.2 Pigmented Villonodular Synovitis Drug Segment by Type
1.2.1 Global Pigmented Villonodular Synovitis Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Cabiralizumab
1.2.3 Emactuzumab
1.2.4 Mcs-110
1.2.5 Nilotinib
1.2.6 Others
1.3 Pigmented Villonodular Synovitis Drug Segment by Applications
1.3.1 Global Pigmented Villonodular Synovitis Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Pigmented Villonodular Synovitis Drug Overall Market
1.4.1 Global Pigmented Villonodular Synovitis Drug Revenue (2014-2025)
1.4.2 Global Pigmented Villonodular Synovitis Drug Production (2014-2025)
1.4.3 North America Pigmented Villonodular Synovitis Drug Status and Prospect (2014-2025)
1.4.4 Europe Pigmented Villonodular Synovitis Drug Status and Prospect (2014-2025)
1.4.5 China Pigmented Villonodular Synovitis Drug Status and Prospect (2014-2025)
1.4.6 Japan Pigmented Villonodular Synovitis Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Pigmented Villonodular Synovitis Drug Status and Prospect (2014-2025)
1.4.8 India Pigmented Villonodular Synovitis Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Pigmented Villonodular Synovitis Drug
2.3 Manufacturing Process Analysis of Pigmented Villonodular Synovitis Drug
2.4 Industry Chain Structure of Pigmented Villonodular Synovitis Drug

3 Development and Manufacturing Plants Analysis of Pigmented Villonodular Synovitis Drug
3.1 Capacity and Commercial Production Date
3.2 Global Pigmented Villonodular Synovitis Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Pigmented Villonodular Synovitis Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Pigmented Villonodular Synovitis Drug Production and Capacity Analysis
4.2 Pigmented Villonodular Synovitis Drug Revenue Analysis
4.3 Pigmented Villonodular Synovitis Drug Price Analysis
4.4 Market Concentration Degree

5 Pigmented Villonodular Synovitis Drug Regional Market Analysis
5.1 Pigmented Villonodular Synovitis Drug Production by Regions
5.1.1 Global Pigmented Villonodular Synovitis Drug Production by Regions
5.1.2 Global Pigmented Villonodular Synovitis Drug Revenue by Regions
5.2 Pigmented Villonodular Synovitis Drug Consumption by Regions
5.3 North America Pigmented Villonodular Synovitis Drug Market Analysis
5.3.1 North America Pigmented Villonodular Synovitis Drug Production
5.3.2 North America Pigmented Villonodular Synovitis Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Pigmented Villonodular Synovitis Drug Import and Export
5.4 Europe Pigmented Villonodular Synovitis Drug Market Analysis
5.4.1 Europe Pigmented Villonodular Synovitis Drug Production
5.4.2 Europe Pigmented Villonodular Synovitis Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Pigmented Villonodular Synovitis Drug Import and Export
5.5 China Pigmented Villonodular Synovitis Drug Market Analysis
5.5.1 China Pigmented Villonodular Synovitis Drug Production
5.5.2 China Pigmented Villonodular Synovitis Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Pigmented Villonodular Synovitis Drug Import and Export
5.6 Japan Pigmented Villonodular Synovitis Drug Market Analysis
5.6.1 Japan Pigmented Villonodular Synovitis Drug Production
5.6.2 Japan Pigmented Villonodular Synovitis Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Pigmented Villonodular Synovitis Drug Import and Export
5.7 Southeast Asia Pigmented Villonodular Synovitis Drug Market Analysis
5.7.1 Southeast Asia Pigmented Villonodular Synovitis Drug Production
5.7.2 Southeast Asia Pigmented Villonodular Synovitis Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Pigmented Villonodular Synovitis Drug Import and Export
5.8 India Pigmented Villonodular Synovitis Drug Market Analysis
5.8.1 India Pigmented Villonodular Synovitis Drug Production
5.8.2 India Pigmented Villonodular Synovitis Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Pigmented Villonodular Synovitis Drug Import and Export

6 Pigmented Villonodular Synovitis Drug Segment Market Analysis (by Type)
6.1 Global Pigmented Villonodular Synovitis Drug Production by Type
6.2 Global Pigmented Villonodular Synovitis Drug Revenue by Type
6.3 Pigmented Villonodular Synovitis Drug Price by Type

7 Pigmented Villonodular Synovitis Drug Segment Market Analysis (by Application)
7.1 Global Pigmented Villonodular Synovitis Drug Consumption by Application
7.2 Global Pigmented Villonodular Synovitis Drug Consumption Market Share by Application (2014-2019)

8 Pigmented Villonodular Synovitis Drug Major Manufacturers Analysis
8.1 Bristol-Myers Squibb Co
8.1.1 Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Production Sites and Area Served
8.1.2 Bristol-Myers Squibb Co Product Introduction, Application and Specification
8.1.3 Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 F. Hoffmann-La Roche Ltd
8.2.1 F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Production Sites and Area Served
8.2.2 F. Hoffmann-La Roche Ltd Product Introduction, Application and Specification
8.2.3 F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Novartis AG
8.3.1 Novartis AG Pigmented Villonodular Synovitis Drug Production Sites and Area Served
8.3.2 Novartis AG Product Introduction, Application and Specification
8.3.3 Novartis AG Pigmented Villonodular Synovitis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Plexxikon Inc
8.4.1 Plexxikon Inc Pigmented Villonodular Synovitis Drug Production Sites and Area Served
8.4.2 Plexxikon Inc Product Introduction, Application and Specification
8.4.3 Plexxikon Inc Pigmented Villonodular Synovitis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served

9 Development Trend of Analysis of Pigmented Villonodular Synovitis Drug Market
9.1 Global Pigmented Villonodular Synovitis Drug Market Trend Analysis
9.1.1 Global Pigmented Villonodular Synovitis Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Pigmented Villonodular Synovitis Drug Regional Market Trend
9.2.1 North America Pigmented Villonodular Synovitis Drug Forecast 2019-2025
9.2.2 Europe Pigmented Villonodular Synovitis Drug Forecast 2019-2025
9.2.3 China Pigmented Villonodular Synovitis Drug Forecast 2019-2025
9.2.4 Japan Pigmented Villonodular Synovitis Drug Forecast 2019-2025
9.2.5 Southeast Asia Pigmented Villonodular Synovitis Drug Forecast 2019-2025
9.2.6 India Pigmented Villonodular Synovitis Drug Forecast 2019-2025
9.3 Pigmented Villonodular Synovitis Drug Market Trend (Product Type)
9.4 Pigmented Villonodular Synovitis Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Pigmented Villonodular Synovitis Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Pigmented Villonodular Synovitis Drug
Table Global Pigmented Villonodular Synovitis Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Pigmented Villonodular Synovitis Drug Production Market Share by Types in 2018
Figure Cabiralizumab Product Picture
Figure Emactuzumab Product Picture
Figure Mcs-110 Product Picture
Figure Nilotinib Product Picture
Figure Others Product Picture
Table Global Pigmented Villonodular Synovitis Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Pigmented Villonodular Synovitis Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Pigmented Villonodular Synovitis Drug Revenue (Million USD) (2014-2025)
Figure Global Pigmented Villonodular Synovitis Drug Production (K Pcs) (2014-2025)
Figure North America Pigmented Villonodular Synovitis Drug Market Size (Million USD) (2014-2025)
Figure Europe Pigmented Villonodular Synovitis Drug Market Size (Million USD) (2014-2025)
Figure China Pigmented Villonodular Synovitis Drug Market Size (Million USD) (2014-2025)
Figure Japan Pigmented Villonodular Synovitis Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Pigmented Villonodular Synovitis Drug Market Size (Million USD) (2014-2025)
Figure India Pigmented Villonodular Synovitis Drug Market Size (Million USD) (2014-2025)
Table Pigmented Villonodular Synovitis Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Pigmented Villonodular Synovitis Drug in 2018
Figure Manufacturing Process Analysis of Pigmented Villonodular Synovitis Drug
Figure Industry Chain Structure of Pigmented Villonodular Synovitis Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Pigmented Villonodular Synovitis Drug Manufacturing Plants Distribution
Table Pigmented Villonodular Synovitis Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Pigmented Villonodular Synovitis Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Pigmented Villonodular Synovitis Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Pigmented Villonodular Synovitis Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Pigmented Villonodular Synovitis Drug Production Share by Manufacturers in 2018
Table Pigmented Villonodular Synovitis Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Pigmented Villonodular Synovitis Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Pigmented Villonodular Synovitis Drug Revenue Share by Manufacturers in 2018
Table Pigmented Villonodular Synovitis Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Pigmented Villonodular Synovitis Drug Production by Regions 2014-2019 (K Pcs)
Table Global Pigmented Villonodular Synovitis Drug Production Market Share by Regions 2014-2019
Figure Global Pigmented Villonodular Synovitis Drug Production Market Share by Regions in 2018
Table Global Pigmented Villonodular Synovitis Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Pigmented Villonodular Synovitis Drug Revenue Market Share by Regions 2014-2019
Figure Global Pigmented Villonodular Synovitis Drug Revenue Market Share by Regions in 2018
Table Global Pigmented Villonodular Synovitis Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Pigmented Villonodular Synovitis Drug Consumption Market Share by Regions 2014-2019
Figure North America Pigmented Villonodular Synovitis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Pigmented Villonodular Synovitis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Pigmented Villonodular Synovitis Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Pigmented Villonodular Synovitis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Pigmented Villonodular Synovitis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Pigmented Villonodular Synovitis Drug Production, Consumption Import and Export (K Pcs)
Figure China Pigmented Villonodular Synovitis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Pigmented Villonodular Synovitis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Pigmented Villonodular Synovitis Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Pigmented Villonodular Synovitis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Pigmented Villonodular Synovitis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Pigmented Villonodular Synovitis Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Pigmented Villonodular Synovitis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Pigmented Villonodular Synovitis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Pigmented Villonodular Synovitis Drug Production, Consumption Import and Export (K Pcs)
Figure India Pigmented Villonodular Synovitis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Pigmented Villonodular Synovitis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Pigmented Villonodular Synovitis Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Pigmented Villonodular Synovitis Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Pigmented Villonodular Synovitis Drug Market Share by Application (2014-2019)
Table Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Production Sites and Area Served
Table Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Product Introduction, Application and Specification
Table Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Main Business and Markets Served
Table F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Production Sites and Area Served
Table F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Main Business and Markets Served
Table Novartis AG Pigmented Villonodular Synovitis Drug Production Sites and Area Served
Table Novartis AG Pigmented Villonodular Synovitis Drug Product Introduction, Application and Specification
Table Novartis AG Pigmented Villonodular Synovitis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG Pigmented Villonodular Synovitis Drug Production Growth Rate (2014-2019)
Table Novartis AG Pigmented Villonodular Synovitis Drug Production Market Share (2014-2019)
Figure Novartis AG Pigmented Villonodular Synovitis Drug Revenue Market Share (2014-2019)
Table Novartis AG Pigmented Villonodular Synovitis Drug Main Business and Markets Served
Table Plexxikon Inc Pigmented Villonodular Synovitis Drug Production Sites and Area Served
Table Plexxikon Inc Pigmented Villonodular Synovitis Drug Product Introduction, Application and Specification
Table Plexxikon Inc Pigmented Villonodular Synovitis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Plexxikon Inc Pigmented Villonodular Synovitis Drug Production Growth Rate (2014-2019)
Table Plexxikon Inc Pigmented Villonodular Synovitis Drug Production Market Share (2014-2019)
Figure Plexxikon Inc Pigmented Villonodular Synovitis Drug Revenue Market Share (2014-2019)
Table Plexxikon Inc Pigmented Villonodular Synovitis Drug Main Business and Markets Served
Figure Global Pigmented Villonodular Synovitis Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Pigmented Villonodular Synovitis Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Pigmented Villonodular Synovitis Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Pigmented Villonodular Synovitis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Pigmented Villonodular Synovitis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Pigmented Villonodular Synovitis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Pigmented Villonodular Synovitis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Pigmented Villonodular Synovitis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Pigmented Villonodular Synovitis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Pigmented Villonodular Synovitis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Pigmented Villonodular Synovitis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Pigmented Villonodular Synovitis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Pigmented Villonodular Synovitis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Pigmented Villonodular Synovitis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Pigmented Villonodular Synovitis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Pigmented Villonodular Synovitis Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Pigmented Villonodular Synovitis Drug by Application (2019-2025)
Table Pigmented Villonodular Synovitis Drug Distributors List
Table Pigmented Villonodular Synovitis Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Bristol-Myers Squibb Co、F. Hoffmann-La Roche Ltd、Novartis AG、Plexxikon Inc、

★調査レポート[世界の色素性絨毛結節性滑膜炎薬市場 2019年] (コード：DATA909X13012)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の色素性絨毛結節性滑膜炎薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のタミフル（オセルタミビル）薬市場 2019年
    DATA909X16262 / QYResearch / 2019年11月22日 / ※本調査レポートは、タミフル（オセルタミビル）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カプセル、経口液に、用途別には、インフルエンザA、インフルエンザBにセグメント区分し、タミフル（オセルタミビル）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・タミフル（オセルタミビル）薬の世界市場概要 ・タミフル（オセルタミビル）薬の製造コスト構成分析 ・タミフル（オセルタミビル）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・タミフル（オセルタミビル）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・タミフル（オセルタミビル）薬のセグメント分析（種類別） （カプセル、経口液）...The global Tamiflu (Oseltamivir) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tamiflu (Oseltamivir) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tamiflu (Oseltamivir) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tamiflu (Oseltamivir) Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の甲状腺機能低下症薬市場 2019年
    DATA909X09522 / QYResearch / 2019年11月20日 / ※本調査レポートは、甲状腺機能低下症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他に、用途別には、病院、診療所、その他にセグメント区分し、甲状腺機能低下症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・甲状腺機能低下症薬の世界市場概要 ・甲状腺機能低下症薬の製造コスト構成分析 ・甲状腺機能低下症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・甲状腺機能低下症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・甲状腺機能低下症薬のセグメント分析（種類別） （BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）...The global Hypothyroidism Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hypothyroidism Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypothyroidism Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hypothyroidism Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Hypothyroidism Drug manufacturing...
  • 世界のコクシジオイデス症薬剤市場 2019年
    DATA909X05597 / QYResearch / 2019年11月15日 / ※本調査レポートは、コクシジオイデス症薬剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他に、用途別には、クリニック、病院、その他にセグメント区分し、コクシジオイデス症薬剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・コクシジオイデス症薬剤の世界市場概要 ・コクシジオイデス症薬剤の製造コスト構成分析 ・コクシジオイデス症薬剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・コクシジオイデス症薬剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・コクシジオイデス症薬剤のセグメント分析（種類別） （VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他）...The global Coccidioidomycosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Coccidioidomycosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Coccidioidomycosis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Coccidioidomycosis Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Coccidioidomycosis Drug manufacturing...
  • 世界のファンコニ貧血薬市場 2019年
    DATA909X07597 / QYResearch / 2019年11月15日 / ※本調査レポートは、ファンコニ貧血薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エルトロンボパグオラミン、EXG-34217、ファンカレン、その他に、用途別には、病院、診療所、その他にセグメント区分し、ファンコニ貧血薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ファンコニ貧血薬の世界市場概要 ・ファンコニ貧血薬の製造コスト構成分析 ・ファンコニ貧血薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ファンコニ貧血薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ファンコニ貧血薬のセグメント分析（種類別） （エルトロンボパグオラミン、EXG-34217、ファンカレン、その他）...The global Fanconi Anemia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Fanconi Anemia Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fanconi Anemia Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Fanconi Anemia Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の緑膿菌肺炎治療薬市場 2019年
    DATA909X13859 / QYResearch / 2019年11月20日 / ※本調査レポートは、緑膿菌肺炎治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アエルシン、EV-035、MEDI-3902、パノバクマブ、その他に、用途別には、病院、クリニック、その他にセグメント区分し、緑膿菌肺炎治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・緑膿菌肺炎治療薬の世界市場概要 ・緑膿菌肺炎治療薬の製造コスト構成分析 ・緑膿菌肺炎治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・緑膿菌肺炎治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・緑膿菌肺炎治療薬のセグメント分析（種類別） （アエルシン、EV-035、MEDI-3902、パノバクマブ、その他）...The global Pseudomonas Aeruginosa Pneumonia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pseudomonas Aeruginosa Pneumonia Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pseudomonas Aeruginosa Pneumonia Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Pseudomonas Aeruginosa Pneumonia Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

    • ◆H&Iグローバルリサーチのお客様（例）◆